Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesThe natural history of non-muscle-invasive transitional cell carcinoma of the bladder
British Journal of Medical & Surgical Urology, 07/01/09
Colquhoun AJ et al. - Non-muscle-invasive (NMI) transitional cell carcinoma (TCC) of the bladder is a common disease that recurs frequently and may progress to more sinister invasive disease. In the absence of a molecular tool that can accurately predict an individual's propensity to tumour recurrence and/or progression, urologists utilise prognostic factors to predict patient outcome. The data obtained regarding prognostic factors are used to describe a rationale follow-up schedule for patients with NMI TCC of the bladder.
Related Articles
Phenotypic and functional characterization of switch memory B cells from patients with oligoarticular juvenile idiopathic arthritis
Arthritis Research & Therapy, 10/06/09
Relevance Score: 68%
Progressive epithelial to mesenchymal transitions in ARCaPE prostate cancer cells during xenograft tumor formation and metastasis
The Prostate, 11/19/09
Relevance Score: 67%
Multidrug Resistance in a Urothelial Cancer Cell Line After 1-Hour Mitomycin C Exposure
The Journal of Urology, 10/29/09
Relevance Score: 67%
Aldehyde Dehydrogenase–Expressing Colon Stem Cells Contribute to Tumorigenesis in the Transition from Colitis to Cancer
Cancer Research, 10/27/09
Relevance Score: 67%
Transitional cell carcinoma of the nasolacrimal sac
Clinical Ophthalmology, 10/23/09
Relevance Score: 67%
Today in Bladder...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09
Laparoscopic versus open radical cystectomy for the management of bladder cancer: Mid-term oncological outcome
International Journal of Urology, 12/04/09
XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy
Journal of Cancer Research & Clinical Oncology, 12/04/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09
Article Search
Sponsor